BackShree Ganesh Remedies Limited Overview

Shree Ganesh Remedies Limited Receivables

Track Shree Ganesh Remedies Limited's receivables ($210M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$211.21M
↓ 14.02% YoYΔ $-34.45M vs prior year quarter

Peer trimmed avg / median

Loading

Shree Ganesh Remedies Limited Receivables History

Loading

Shree Ganesh Remedies Limited vs. peers: Receivables Comparison

Loading

Shree Ganesh Remedies Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shree Ganesh Remedies Limited (SGRL.BO) FAQ

As of the most recent data (September 2026), SGRL.BO shows a receivables of $210M. That compares with $250M in the prior-year period — down 14.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SGRL.BO's receivables is now $210M (was $250M) — a 14.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shree Ganesh Remedies Limited is outperforming or lagging.

Tracking SGRL.BO's receivables over time shows whether Shree Ganesh Remedies Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $210M That compares with $250M in the prior-year period — down 14.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Shree Ganesh Remedies Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $210M) with ownership activity and broader fundamentals.

Questions & Answers